hotspot -WSS

hotspot

author：hotspot 2025-09-27 20:26:19 - browse：118

Light micrograph of a fatty liver — Large vacuoles of triglyceride fat, accumulated inside liver cells. Adobe

SAN DIEGO — An experimental obesity drug from Eli Lilly significantly reduced liver fat in a small analysis, supporting further studies of the treatment against nonalcoholic fatty liver disease, an increasingly common condition that lacks approved treatments.

Among 98 patients with nonalcoholic fatty liver disease, those on the highest dose tested of the drug, retatrutide, experienced an 86% decrease in liver fat over 48 weeks, with most of the reduction occurring early on in treatment, according to data presented here at the American Diabetes Association conference Monday.

Additionally, 93% of people on the highest dose achieved resolution of fatty liver disease, defined as having 5% or less liver fat.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Future doctors need a strong humanities education

WSS

Mass General, Mayo Clinic look to monetize custom

Head of FDA's diagnostics center, who led through Covid, retires

Medicare bonuses could stop drug shortages under Senate plan

STAT Summit: The economic case for universal basic health care

Flu vaccine reformulation won't be easy, manufacturers warn

HPV vaccine, cervical cancer study delivers historic results

leisure time

hotspot

focus

Medicare details structure of new drug price negotiation program

To bolster infectious disease surveillance, genomics powerhouses team up

What does generative AI mean for health care? We asked experts

STAT Summit: Ending the crisis of Black deaths in the U.S.

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Microsoft launches AI tool for clinical documentation through Epic

Bright Health sells Medicare Advantage business to Molina

A pediatrician calls for Congress to pass the child tax credit deal

Medicare proposal to cover medical devices draws a mixed reaction

Health tech investors get more selective as pandemic boom fades

Wikipedia

STAT Readout: Friday, Oct. 20 biotech updates

Study on Amgen’s bispecific immunotherapy produces positive data

STAT Readout: Friday, Oct. 20 biotech updates

There's an unseen cost to disruptive road

TikTok, Instagram influencers need more rules for drug ads

Medicare drug price lawsuits could be good politics for Biden

knowledge

leisure time

Wikipedia

hotspot